Donaldson Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-43,402
Closed -$634K 250
2020
Q4
$634K Buy
43,402
+33,402
+334% +$443K 0.04% 133
2020
Q3
$142K Buy
+10,000
New +$153K 0.01% 217
2020
Q2
Sell
-73,003
Closed -$301K 207
2020
Q1
$301K Buy
73,003
+10,000
+16% +$46.9K 0.03% 163
2019
Q4
$303K Hold
63,003
0.02% 184
2019
Q3
$382K Buy
+63,003
New +$393K 0.03% 140
2019
Q2
Sell
-63,003
Closed -$447K 187
2019
Q1
$447K Hold
63,003
0.04% 107
2018
Q4
$306K Sell
63,003
-20,000
-24% -$104K 0.03% 126
2018
Q3
$610K Hold
83,003
0.05% 105
2018
Q2
$530K Buy
83,003
+15,075
+22% +$99.6K 0.05% 105
2018
Q1
$370K Hold
67,928
0.04% 122
2017
Q4
$283K Buy
67,928
+1,500
+2% +$9.03K 0.03% 139
2017
Q3
$640K Hold
66,428
0.07% 98
2017
Q2
$786K Hold
66,428
0.09% 85
2017
Q1
$852K Buy
66,428
+3
+0% +$36 0.1% 80
2016
Q4
$813K Hold
66,425
0.1% 87
2016
Q3
$784K Hold
66,425
0.1% 75
2016
Q2
$578K Hold
66,425
0.08% 86
2016
Q1
$350K Buy
66,425
+3,010
+5% +$16.8K 0.05% 103
2015
Q4
$492K Buy
63,415
+1,965
+3% +$15.1K 0.07% 92
2015
Q3
$484K Hold
61,450
0.07% 93
2015
Q2
$557K Buy
+61,450
New +$620K 0.08% 90
2015
Q1
Sell
-42,000
Closed -$572K 157
2014
Q4
$572K Hold
42,000
0.09% 89
2014
Q3
$377K Buy
+42,000
New +$452K 0.06% 98

Other funds holding GNMK

Donaldson Capital Management's GNMK Position: Q1 2021 in Review

Donaldson Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 43,402 shares — an estimated $634K sold.

Donaldson Capital Management first reported a position in GNMK in Q3 2014 and held it in 23 quarters. The position peaked at $852K in Q1 2017. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Donaldson Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Donaldson Capital Management sold 43,402 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $634K.
  • Donaldson Capital Management first reported a position in GenMark Diagnostics, Inc in Q3 2014 and held it in 23 quarters.
  • Donaldson Capital Management's GenMark Diagnostics, Inc position peaked at $852K in Q1 2017.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Donaldson Capital Management's 13F filing for Q1 2021, filed 5 May 2021.